These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6388664

  • 1. Effect of hepatic dysfunction on oral cyclosporin pharmacokinetics in marrow transplant patients.
    Yee GC, Kennedy MS, Storb R, Thomas ED.
    Blood; 1984 Dec; 64(6):1277-9. PubMed ID: 6388664
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of intravenous cyclosporine in bone marrow transplant patients. Comparison of two assay methods.
    Yee GC, Kennedy MS, Storb R, Thomas ED.
    Transplantation; 1984 Nov; 38(5):511-3. PubMed ID: 6388073
    [Abstract] [Full Text] [Related]

  • 3. Clinical pharmacokinetics of cyclosporin.
    Ptachcinski RJ, Venkataramanan R, Burckart GJ.
    Clin Pharmacokinet; 1986 Nov; 11(2):107-32. PubMed ID: 3514043
    [Abstract] [Full Text] [Related]

  • 4. Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia.
    Mrsić M, Labar B, Bogdanić V, Nemet D, Pavletić Z, Plavsić F, Dobrić I, Marusić M, Francetić I, Kastelan A.
    Bone Marrow Transplant; 1990 Aug; 6(2):137-41. PubMed ID: 2207450
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
    Stockschlaeder M, Storb R, Pepe M, Longton G, McDonald G, Anasetti C, Appelbaum F, Doney K, Martin P, Sullivan K.
    Br J Haematol; 1992 Jan; 80(1):49-54. PubMed ID: 1536809
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.
    Barrett AJ, Kendra JR, Lucas CF, Joss DV, Joshi R, Pendharkar P, Hugh-Jones K.
    Br Med J (Clin Res Ed); 1982 Jul 17; 285(6336):162-6. PubMed ID: 6807391
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation.
    Atkinson K, Biggs J, Darveniza P, Boland J, Concannon A, Dodds A.
    Transplantation; 1984 Jul 17; 38(1):34-7. PubMed ID: 6377609
    [Abstract] [Full Text] [Related]

  • 14. Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
    Gluckman E, Devergie A, Lokiec F.
    Transplant Proc; 1988 Jun 17; 20(3 Suppl 3):461-9. PubMed ID: 3291282
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.